Rodedawg Intl. Ind, Inc. (OTC: RWGI) Provides Shareholder Update

Rodedawg Intl. Ind, Inc. (OTC: RWGI) Provides Shareholder Update

Sales Channel Expansion Set for 2024 and Beyond COSTA MESA,‌ ‌CA‌, April 16th,‌ ‌2024‌ ‌- Rodedawg International Industries, Inc. (OTC: RWGI) proudly announces the Company, with our wholly owned subsidiary, Parabola Mgmt. LLC, has expanded into a multi-faceted...

PRISM MarketView – Biotech Breakfast

PRISM MarketView – Biotech Breakfast

Mobile-Health Network Solutions (MNDR) IPOs; Q32 Bio Surges; EMA Concludes GLP-1 Drugs Not Associated with Suicidal Thoughts New York, N.Y., April 15, 2024 - PRISM MarketView - Healthcare equities finished lower on Friday, in line with broad declines across the...

ONCOCYTE REPORTS Full Year 2023 FINANCIAL RESULTS

ONCOCYTE REPORTS Full Year 2023 FINANCIAL RESULTS

Conference Call on Friday, April 12, 2024 at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, April 12, 2024 - Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the year ended December 31, 2023. Recent Highlights...

ONCOCYTE REPORTS Full Year 2023 FINANCIAL RESULTS

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

-     Bio-Rad expects to make equity investment in support of deal -     Agreement provides for global exclusivity in transplant monitoring commercialization -     Bio-Rad granted subsequent investment option upon FDA clearance IRVINE, CA, April 11, 2024 - Oncocyte...